Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Mental health

HRT ‘may help prevent Alzheimer’s disease’ in at-risk women

Alzheimer’s affects an estimated one in 14 people over the age of 65 and one in every six people over the age of 80.

The Independent UK

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

The Conversation

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

ADHD services ‘swamped’, say experts as more UK women seek diagnosis

Warnings of ‘great cost’ to individuals, workplaces and the economy as people struggle to access diagnosis and treatment

The Guardian - UK

‘A lifeline’: mental health camps bring peace of mind to thousands in rural Assam

India’s severe shortage of mental health professionals and treatment funding leaves many patients without options. But a pioneering programme is working to get lives back on track

The Guardian - UK

A new Alzheimer’s drug has been approved. What to know about lecanemab

A new drug that appears to slow early Alzheimer’s disease is coming to the market.

Tribune News Service

‘It’s made me who I am’: Johnny Vegas diagnosed with ADHD at 52

British actor and comedian says condition has made him disorganised but ‘chaos’ may have helped his standup performance

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

Blood markers could help identify rare, inherited form of Alzheimer’s disease

Findings could lead to earlier detection of the disease

The Independent UK

Blood markers ‘may reveal rare form of Alzheimer’s 10 years before symptoms'

Researchers found that a protein called GFAP can appear in blood samples of people who are in the very early stages of the neurodegenerative disease

Wales Online

New Alzheimer's blood test could detect disease '10 years' before symptoms appear

Scientists have discovered that a type of protein could be a blood-marker for early signs of the disease.

Daily Record

Blood markers ‘may reveal rare form of Alzheimer’s 10 years before symptoms’

Scientists hope their work could lead to earlier detection.

The Independent UK

Concern as proportion of children in England on antipsychotics doubles

Researchers find overall percentage increase from 0.06% in 2000 to 0.11% in 2019 although safety in children not fully established

The Guardian - UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.

ABC News

Row over 'template letter' to inform patients of alleged mental health crisis in Tasmania's north

The wording of a letter informing patients their mental health service is in crisis is "a template, in case it's needed in the future", Tasmania's health department says — but a health union says it shows mental health care is "in such a state it might be embarrassing to admit".

Chicago Sun-Times

Finally, a new drug slows Alzheimer’s, but is it worth the price for modest benefit?

Leqembi can slow early progression by months but has safety concerns. Most patients will likely have to wait months to get the IV drug, which will cost about $26,500 a year. Insurers need to decide whether and how much to cover it. Medicare isn’t expected to pay for it until…

The Independent UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

Get all your
news in one place.

100's of premium titles.
One news app.

Liverpool Echo

ADHD symptoms and warning signs including poor sleep

Sometimes ADHD is not recognised when someone was a child, and they are diagnosed later as an adult

Salon

Fixing the youth mental health crisis

Students are more stressed than ever — and the best (and most obvious) solution is hiring enough school counselors

Inverse

Practicing one whimsical activity may stave off brain aging — study

Opinion: Lifestyle interventions like social ballroom dancing are a promising, noninvasive, and cost-effective path toward staving off dementia as we – eventually – leave the Covid-19 pandemic behind.

The Independent UK

Scientists reveal how to spot signs of dementia nine years before diagnosis

Early intervention could reduce your risk of developing dementia-related disease

Asharq Al-Awsat

US Approves New Drug to Treat Alzheimer's Disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized…

Liverpool Echo

Parkinson's symptom that starts years before hand tremors

Parkinson's is a degenerative, neurological condition with no cure

The Philadelphia Inquirer

The FDA approved the first Alzheimer’s drug that may really work. A Penn physician explains why you probably can’t get it, yet

The FDA on Friday authorized the use of the Alzheimer’s drug lecanemab, the first drug clearly shown to slow the progress of the debilitating brain disease.

1 … 146 147 148 149

People

Ahmed Ali

16 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

University of Cambridge

University of Edinburgh

205 stories

Alzheimer Research UK

University of Manchester

132 stories

Ant

91 stories

National Institutes of Health

86 stories

Eisai

84 stories

Karolinska Institutet

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.